Skip to main content
. 2022 Feb 14;36(3):301–313. doi: 10.1007/s40263-021-00890-1

Table 1.

Demographic and baseline characteristics of patients (full analysis set)

HSK3486 (n = 134) Propofol (n = 133) P-value
Age, years 46.60 ± 15.31 46.90 ± 13.98 0.849
Age range, n (%) 1.000
 ≥ 18 and < 65 years 119 (88.8) 119 (89.5)
 ≥ 65 and < 80 years 15 (11.2) 14 (10.5)
Gender, n (%) 0.159
 Male 62 (46.3) 73 (54.9)
 Female 72 (53.7) 60 (45.1)
Height (m) 1.61 ± 0.08 1.63 ± 0.08 0.073
Weight (kg) 60.60 ± 9.47 61.13 ± 9.18 0.642
BMI (kg/m2) 23.20 ± 2.64 22.92 ± 2.60 0.374
ASA classification, n (%) 0.151
 Grade I 63 (47.0) 50 (37.6)
 Grade II 68 (50.7) 82 (61.7)
 Grade III 3 (2.2) 1 (0.8)
MOAA/S 5.0 (0.00) 5.0 (0.00) 1.000
Diagnostic and therapeutic category, n (%) 1.000
 General diagnostic 122 (91.0) 121 (91.0)
 Advanced diagnostic 10 (7.5) 10 (7.5)
 Therapeutic 2 (1.5) 2 (1.5)
Modified Mallampati score, n (%) 0.417
 Grade I 90 (67.2) 83 (62.4)
 Grade II 44 (32.8) 50 (37.6)

Data are given as the mean ± SD or numbers with percentages in parentheses

ASA American Society of Anesthesiologists, BMI body mass index, MOAA/S Modified Observer Assessment of Alertness/Sedation, SD Standard deviation